Chemical Works of Gedeon Richter Plc Logo

Chemical Works of Gedeon Richter Plc

Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.

RICHT | BUD

Overview

Corporate Details

ISIN(s):
HU0000067624 (+3 more)
LEI:
549300J6ZJW5IH4WEE46
Country:
Hungary
Address:
GYOMROI UT 19-21, 1103 BUDAPEST
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Chemical Works of Gedeon Richter Plc. is a multinational, vertically integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of medicinal products. The company's core therapeutic areas include women's health, central nervous system disorders, and cardiovascular diseases, with additional activity in oncology. Its portfolio consists of original research drugs, active pharmaceutical ingredients (APIs), and generic medicines. Founded in 1901, Gedeon Richter focuses on delivering high-value therapies to improve the quality of life for patients globally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 08:59
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 226.8 KB
2025-11-27 08:59
Transaction in Own Shares
Transactions with Treasury Shares
English 321.4 KB
2025-11-26 09:12
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 192.9 KB
2025-11-26 09:12
Transaction in Own Shares
Transactions with Treasury Shares
English 295.6 KB
2025-11-25 09:03
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 229.2 KB
2025-11-25 09:03
Transaction in Own Shares
Transactions with Treasury Shares
English 199.8 KB
2025-11-06 12:59
Related Party Transaction
Subsidiaries transactions Q1-Q3 2025
English 179.1 KB
2025-11-06 12:59
Related Party Transaction
Subsidiaries transactions Q1-Q3 2025
Hungarian 238.5 KB
2025-11-06 06:03
Investor Presentation
edeon Richter Plc. - Company presentation Q3 2025
Hungarian 1.4 MB
2025-11-06 06:03
Investor Presentation
edeon Richter Plc. - Company presentation Q3 2025
English 1.4 MB
2025-10-31 14:11
Regulatory News Service
Voting rights, registered capital
Hungarian 244.7 KB
2025-10-31 14:11
Declaration of Voting Results & Voting Rights Announcements
Voting rights, registered capital
English 207.0 KB
2025-10-09 10:32
Regulatory News Service
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
Hungarian 1.4 MB
2025-10-09 10:32
Interim Report
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
English 1.4 MB
2025-09-30 14:34
Declaration of Voting Results & Voting Rights Announcements
Voting rights, registered capital
Hungarian 243.0 KB

Automate Your Workflow. Get a real-time feed of all Chemical Works of Gedeon Richter Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chemical Works of Gedeon Richter Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chemical Works of Gedeon Richter Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VivoSim Labs, INC. Logo
Offers 3D human tissue models for predictive toxicology testing to accelerate drug discovery.
United States of America
VIVS
Develops innovative, non-narcotic drugs for pain and central nervous system (CNS) diseases.
South Korea
082800
VOLITIONRX LTD Logo
Develops epigenetic blood tests for early cancer and sepsis detection in human/veterinary markets.
United States of America
VNRX
vTv Therapeutics Inc. Logo
Develops oral small molecule drugs for type 1 diabetes and other chronic conditions.
United States of America
VTVT
VYNE Therapeutics Inc. Logo
Clinical-stage biopharma developing novel therapies for immuno-inflammatory diseases.
United States of America
VYNE
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan
4512
Wave Life Sciences Ltd. Logo
Developing RNA-based medicines for severe genetic diseases like DMD and Huntington's disease.
United States of America
WVE
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea
010600
Werewolf Therapeutics, Inc. Logo
Developing tumor-activated immunotherapies for a localized immune attack on cancer.
United States of America
HOWL
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea
016580

Talk to a Data Expert

Have a question? We'll get back to you promptly.